Lunch Brief: NMNH: Next generation NAD⁺ innovation for cellular energy and active aging (Effepharm)

Explore the emerging science of NMNH as a next-generation approach to NAD⁺ support. This session will examine how NMNH differs from established NAD⁺ precursors, its role in cellular energy metabolism and the latest clinical evidence supporting its potential in active aging. Attendees will gain practical insights into how new NAD⁺ innovations may translate into future product development opportunities.

Key Takeaways:

• Understand the science and metabolism of NMNH.
• Explore how NMNH supports NAD⁺ levels and cellular energy.
• Review emerging clinical evidence related to NMNH and active aging.
• Identify product development opportunities for NMNH in healthy-aging formulations.

Join us to explore the potential of NMNH as a next-generation NAD⁺ innovation for active-aging products.

Speakers:

• Dr. Richard Kaszynski
• Dr. Jianjun Yu

Click here to add to your badge registration.

**Registration for this session is subject to approval by the sponsoring company, which reserves the right to manage final attendance.